Efficacy and safety of thalidomide in preventing oral mucositis in patients with nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy: A multicenter, open‐label, randomized controlled trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of thalidomide in preventing oral mucositis in patients with nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy: A multicenter, open‐label, randomized controlled trial

Published:2021-12-15 Issue: Volume: Page:
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Liang Leifeng¹,Liu Zhibing²,Zhu Haisheng¹,Wang Hongqian³,Wei Yan⁴,Ning Xuejian⁵,Shi Zhiling²,Jiang Liujun¹,Lin Zhan¹,Yan Haolin¹,Wang Rensheng²^ORCID,Hu Kai²^ORCID

Affiliation:

1. Department of Oncology Sixth Affiliated Hospital of Guangxi Medical UniversityFirst People's Hospital of Yulin Yulin China

2. Department of Radiation Oncology First Affiliated Hospital of Guangxi Medical University Nanning China

3. Department of Radiation Oncology Red Cross Hospital of Yulin Yulin China

4. Department of Oncology Guigang People's Hospital Guigang China

5. Department of Oncology Liuzhou Hospital of Chinese Medicine Liuzhou China

Funder

Natural Science Foundation of Guangxi Province

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.34074

Reference39 articles.

1. Nasopharyngeal carcinoma;Chen YP;Lancet,2019

2. Nasopharyngeal carcinoma incidence and mortality in China, 2013;Wei KR;Chin J Cancer,2017

3. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099;Al‐Sarraf M;J Clin Oncol,1998

4. Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally‐advanced nasopharyngeal carcinoma: NPC‐9901 trial by the Hong Kong Nasopharyngeal Cancer Study Group;Lee AWM;J Clin Oncol,2005

5. A randomized, double‐blind, placebo‐controlled trial of probiotics to reduce the severity of oral mucositis induced by chemoradiotherapy for patients with nasopharyngeal carcinoma;Jiang CL;Cancer,2019

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of probiotics in the treatment of oral mucositis in head and neck cancer patients: A systematic review and meta-analysis;Microbial Pathogenesis;2024-08

2. Summary of the best evidence for nutritional support programs in nasopharyngeal carcinoma patients undergoing radiotherapy;Frontiers in Nutrition;2024-07-31

3. Systemic Anti-Inflammatory Agents in the Prevention of Chemoradiation-Induced Mucositis: A Review of Randomised Controlled Trials;Biomolecules;2024-05-06

4. Emerging pharmacotherapy trends in preventing and managing oral mucositis induced by chemoradiotherapy and targeted agents;Expert Opinion on Pharmacotherapy;2024-04-12

5. Thalidomide for management of refractory oral mucosal diseases;Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3